Quantcast Mike Terretti's Daily Pharma News
Mike Terretti's Daily Pharma News By Mike Terretti 919-781-0400x112
Mike Terretti’s focus is the Pharmaceutical and Biotechnology Industries in Executive Recruitment. THe following information drives all the growth and opportunity in our market.
Mike Terretti's Daily Pharma News >> BIOTECH November 24, 2009 members login here
Public San Francisco -Global Clinical Research -Oncology 
My Public San Francisco area client is focused on the development and commercialization of novel therapeutics for oncology.
This position in the overall management of the clinical project team and with the development of clinical plans and implementation of clinical trials.
Executive Director, Global Clinical Research and Development-Oncology

Essential functions include, but are not limited to the following:
• Oversee... Read More    Add Comment

More
>>  BIOTECH
Cephalon stock drops after trial data disappoint
Reuters Health - 5 Hours ago
-0400 (Reuters Health) * Reports disappointing results of esophagus drug trial * Cephalon shares drop as much as 10 pct * Cephalon delays decision on Ception acquisition By Toni Clarke BOSTON, (Reuters)
UPDATE 5-Cephalon stock drops after trial data disappoint London South East
all 1 news articles >>      Add Comment

Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical
Bioscience Technology Online - 6 Hours ago
screens for the effect of altered gene dosage on drug sensitivity in the model organism Saccharomyces cerevisiae provide only a partial picture of the mechanism of action of a drug. RESULTS: Using the
     Add Comment

Report on GM Crops and Pesticide Use Draws Fire from Producers
Chemical Week - 6 Hours ago
A report on the impact of genetically modified (GM) crops after the first 13 years of commercial use in the U.S. finds that GM crops have increased pesticide use 318.4 million pounds compared to...
Report on GM Crops and Pestice Use Draw Fire from Producers Chemical Week
all 1 news articles >>      Add Comment

Maize genome mapped - Premium content
Nature - 7 Hours ago
Hat off to these people working hard on the maize genome sequencing project. This is a great achievement. While the communities are celebrating this breakthrough, Science, Nature, and NSF should investigate
     Add Comment

Global Study of Salmon from Dalhousie University, Ecotrust, and the Swedish Institute
World Energy Source - 6 Hours ago
(BUSINESS WIRE)--Popular thinking about how to improve food systems for the better often misses the point, according to the results of a three-year global study of salmon production systems from Dalhousie
Global Study of Salmon Shows: "Sustainable" Food Production Isn't So Sustainable YubaNet
all 1 news articles >>      Add Comment

Merck Serono to Invest More than â,¬150M in R&D Center in China
Genetic Engineering News - 3 Hours ago
Inside Industry GEN News Highlights GEN News Highlights Merck Serono, a division of Merck KGaA, will strengthen its global research and development capabilities by establishing a global R&D center
Merck Serono to Invest More than â,¬150M in R&D Center in China Genetic Engineering News
all 1 news articles >>      Add Comment

Genome-wide association studies in developing countries raise important new ethical
Genetic Engineering News - 5 Hours ago
Typically conducted in richer, developed countries but now increasingly done in the developing world, genome wide association (GWA) studies raise a host of ethical issues that must be addressed, argues
     Add Comment

Technology Showcase: White Biotechnology for Green Products and Chemicals
World Energy Source - 6 Hours ago
(BUSINESS WIRE)--Biotechnology Industry Organization (BIO): WHAT: For reporters attending the UN Climate Change Conference in Copenhagen, the Biotechnology Industry Organization (BIO) and BioEuropa will
     Add Comment

Biometric Access Control Installed at Leading U.S. Pharmacy Benefit Manager
U.S.Pharmacist - 4 Hours ago
IdentiPHI, Inc.'s SAFsolution 5 Enterprise Edition has been chosen by one of the largest pharmacy benefit managers (PBMs) in the country to enhance biometric authentication and security access across
     Add Comment

One of Nations Largest Pharmacy Benefits Managers Selects IdentiPHI Enterprise Biometric
U.S.Pharmacist - 4 Hours ago
One of Nationâ??s Largest Pharmacy Benefits Managers Selects IdentiPHI Enterprise Biometric Software for Network Security Upgrade Staff IdentiPHI, Inc., an innovative leader in enterprise security solutions
     Add Comment

EU is "politically dysfunctional" about GMOs, says Byrne
Agra Net - 4 Hours ago
There is a 'huge gap in political leadership' on genetically modified organisms in Europe, former European Health Commissioner David Byrne said late last month in a forceful attack both on leadership
     Add Comment

Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Freshnews.com - 4 Hours ago
Companies mentioned in this article: Amgen THOUSAND OAKS, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for
Amgen Recognized for Best Pipeline and Best New Drug at Scrip PR Newswire via MSN Money
all 1 news articles >>      Add Comment

Human Genome Sciences and Aegera Therapeutics Announce Initiation of Clinical Trial
Pharmacy Choice - 6 Hours ago
- Primary study objectives include evaluation of safety and tolerability, as well as selection of a recommended dose for Phase 2 trials - - Continued progress on IAP inhibitor program - ROCKVILLE, Md.
Human Genome Sciences commences patient dosing in its HGS1029 inhibitor trial News-Medical.Net
Human Genome Sciences and Aegera Therapeutics Announce Initiation Business Wire via MSN Money
all 2 news articles >>      Add Comment

Genentech Oceanside�s Continuous Improvement Journey
Pharmaceutical Manufacturing Magazine - 7 Hours ago
A talk with associate director of manufacturing Kawa Chiu about initial, and lasting, Right First Time successes.
     Add Comment

Merck Serono to Expand Research and Development Presence in China
PharmiWeb - 7 Hours ago
- China's Research and Development Organization Will Become the Fourth Key R&D Hub for Merck Serono Worldwide- Merck Serono Plans to Invest More Than 150 Million EURPR wireGENEVA, November 23 GENEVA,
::: Merck Serono to Expand Research and Development Presence in China Biotech Intelligence
Merck Serono Establishing R&D Hub In China BioSpace
all 5 news articles >>      Add Comment

YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR,
Forbes.com - 8 Hours ago
MISSISSAUGA, ON YM BioSciences understands that the dose-escalation Phase I/II study by Cytopia is investigating the safety and tolerability of CYT387 administered as a daily oral capsule dose in 30-60
     Add Comment

Researchers at Signature Genomics Attribute Diverse Spectrum of Neurological Problems
Reuters - 8 Hours ago
SPOKANE, Wash.--(Business Wire)-- Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental
     Add Comment

2 Fired From GM Plant After Go-Slow
St. Petersburg Times Russia - 9 Hours ago
Vedomosti The management of General Motors' St. Petersburg plant has fired two workers for carrying out a 'go-slow' strike - union leader Yevgeny Ivanov and member Olga Shafikova. Ivanov received his
     Add Comment

Cephalon Drug Shows Mixed Results - Zibb.com
Zibb - 11 Hours ago
Company: Cephalon, Inc (CEPH) Cephalon (CEPH) shares are falling today on disappointing results from a drug to treat pediatric eosinophilic esophagitis, an inflammation of the esophagus. The results come
Cephalon Shares Dropped 9% After Mixed Drug Trial Results (CEPH) Individual.com
all 1 news articles >>      Add Comment

Origin Agritech shares surge on GM corn marketing approval
Forbes.com - 15 Hours ago
Nov 23 (Reuters) - Shares of Origin Agritech Ltd soared 67 percent to a year-high on Monday, after the Chinese supplier of crop seeds said on Saturday that its genetically modified phytase corn received
Early-Market Movers: Origin Agritech Limited, Ciena Corp FOXNews.com
all 1 news articles >>      Add Comment

Ridgewater Equity Reviews the Following Equities Human Genome Sci...
Zibb - 18 Hours ago
Companies: Advanced Battery Technologies Inc (ABAT), Human Genome Sciences, Inc. (HGSI), Intel Corp. (INTC), Intuit Inc. (INTU), Linn Energy LLC (LINE) Economic data fails to come to rescue for stocks
Ridgewater Equity Detailed Review on Western Refining Inc., North... Zibb
Ridgewater Equity Reviews the Following Equities Human Genome Sciences Inc., Intuit TradingMarkets
all 3 news articles >>      Add Comment

Biotech trust targets 50m share issue
Investment Week - 11 Hours ago
Biotech Growth trust is planning to raise up to 50m through a new share offering. OrbiMed Capital's Geoffrey Hsu, investment manager to the 70m trust, says the sector has traded on historically low valuations
     Add Comment

Diagnosing the future of genomics
Scientific American - 11 Hours ago
Eric Green discusses his priorities as newly appointed director of the US National Human Genome Research Institute. Erika Check Hayden Eric Green is the new director of the US National Human Genome Research
     Add Comment

Clal Biotech invests in Biocancell: Biocancell founder Prof. Avraham Hochberg: The
TradingMarkets - 11 Hours ago
(Globes - McClatchy-Tribune Information Services via COMTEX) -- IDBJF | Quote | Chart | News | PowerRating -- Cancer drug development company Biocancell Therapeutics Ltd. (TASE:BICL) has obtained a $500,000
Clal Biotech invests in Biocancell Globes
all 1 news articles >>      Add Comment

Revisiting A Few Hot Biotech Stocks Of 2009
RTTNews.com - 12 Hours ago
The biotechnology sector is a risky investment arena, but investing in such stocks can also be highly rewarding and exciting. A few biotech stocks - DNDN, TRGT, HGSI, VNDA and PLX - covered by our site
     Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.